PURELON 1.8 %
Cohesive Ophthalmic Viscosurgical Device (OVD)
Overview
PURELON 1.8% represents the next level of cohesive viscoelastic performance.
With 18 mg/mL sodium hyaluronate of 3,200,000 Daltons molecular weight, it provides superior protection of corneal endothelium, outstanding space maintenance, and unmatched clarity during all stages of cataract and anterior segment surgery.
Designed for longer and complex procedures, it ensures smooth manipulation and reliable intraocular pressure control.
Technical Specifications
Composition: Sodium Hyaluronate in Phosphate Saline Buffer Colorless, clear, sterile, non-pyrogenic.
HA Concentration: 18 mg/mL (1.8 %)
Molecular Weight: 3,200,000 Daltons
Classification: Cohesive
Viscosity: 400,000-600,000 mPa·s
pH: 6.8 – 7.6
Osmolality: 280 – 400 mOsm/kg
Storage Temperature: +2 °C to +25 °C
Shelf Life: 36 months
Packaging: 0.55 / 0.85 / 1.0 / 1.5 mL prefilled glass syringe in sterile blister – includes patient labels & IFU
Usage Condition: Ready to use — no pre-cooling required
Key Features
High-viscosity cohesive OVD for demanding surgical procedures
Provides maximum chamber depth and shape stability
Exceptional optical clarity and corneal protection
Long-lasting viscoelastic retention
Sterile, single-use glass syringe with smooth injectability
Recommended Use
PURELON 1.8% is recommended for advanced and prolonged surgeries, including phacoemulsification and IOL implantation, where maximum stability and tissue protection are required.
Interested in PURELON 1.8 % for your practice?
Contact us to request product details, technical documents, or distributor information.